Sign in
4

Changes in Ownership

Benitec Biopharma Inc. Filed Acc 0001062993-24-005969

Options or other derivatives

  • Executive Director acquired 200,004 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Boston Megan Executive Director 2024-03-06 Grant or award · Options (right to buy) +200,004 200,004 D
Loading xslF345X05/form4.xml…